RNA interference (RNAi) technology is making revolutionary changes in therapeutics, diagnosis and health technology. Messenger RNA (mRNA) being the key component of communication between the ribosomes ...

Dublin, Sept. 21, 2020 (GLOBE NEWSWIRE) -- The "RNAi - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. The report compares RNAi ...

The global market for RNAi technology is estimated to increase from $2.1 billion in 2023 to reach $4.8 billion by 2029, at a compound annual growth rate (CAGR) of 14.8% from 2024 through 2029. The ...

According to SNS Insider, the global RNAi Technology Market was valued at USD 3.02 billion in 2024 and is projected to reach USD 9.03 billion by 2032, expanding at a CAGR of 14.68% over 2025–2032. RNA ...

(MENAFN- PR Newswire) RNAi therapeutics are revolutionizing disease treatment, with six approved therapies primarily targeting rare genetic disorders. As many potential disease targets still lack ...

Dublin, May 21, 2025 (GLOBE NEWSWIRE) -- The "RNAi Technology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to ResearchAndMarkets.com's offering.

DUBLIN, IRELAND--(Marketwired - Jul 10, 2014) - Research and Markets (http://www.researchandmarkets.com/research/k7rqtw/rnai) has announced the addition of a new ...

Ribonucleic acid interference delivery remains one of the underdeveloped aspects of the overall RNAi market. The limitations of current delivery technologies - with regard to both in-vitro delivery to ...

Nastech Pharmaceutical Company Inc. has announced the expansion of its RNAi therapeutics pipeline by initiating an RNAi therapeutics program targeting influenza and respiratory diseases. In connection ...

The MarketWatch News Department was not involved in the creation of this content. AUSTIN, Texas and TOKYO, Sept. 4, 2025 /PRNewswire/ -- According to DataM Intelligence, the RNAi technology market ...